Autolus Therapeutics Plc (AUTL)
1.67
+0.03
(+1.83%)
USD |
NASDAQ |
Feb 20, 16:00
1.675
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics EPS Diluted (Quarterly) : -0.2954 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1348 |
| Mereo BioPharma Group Plc | -0.0436 |
| Bicycle Therapeutics Plc | -0.8474 |
| DBV Technologies SA | -1.207 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -78.62M |
| Revenue (Quarterly) | 21.06M |
| Total Expenses (Quarterly) | 99.69M |
| Enterprise Value | 400.73M |
| Gross Profit Margin (Quarterly) | -51.21% |
| Profit Margin (Quarterly) | -373.3% |
| Earnings Yield | -50.54% |
| Normalized Earnings Yield | -50.54 |